dc.contributor | Departament de Salut |
dc.contributor.author | Servei Català de la Salut. Gerència del Medicament |
dc.date.accessioned | 2021-11-15T12:10:53Z |
dc.date.available | 2021-11-15T12:10:53Z |
dc.date.issued | 2020-10-27 |
dc.identifier.citation | Servei Català de la Salut. Gerència del Medicament. Document informatiu dels fàrmacs d'acció lenta sobre els símptomes de l'artrosi (SYSADOA). Barcelona: Servei Català de la Salut; 2020. |
dc.identifier.uri | https://hdl.handle.net/11351/6548 |
dc.description | Slow-acting drugs; Osteoarthritis; Symptoms |
dc.description.abstract | Slow-acting drugs on the symptoms of osteoarthritis or SYSADOA (from the acronym in
English, SYmptomatic Slow Action Drugs for OsteoArthritis) are glucosamine (a
aminomonosaccharide, in the form of sulphate or hydrochloride), chondroitin sulphate (a glycosaminoglycan) and diacerein (a product related to anthraquinones). They are
authorized and used as a treatment for the relief of symptoms of mild and moderate osteoarthritis. |
dc.language.iso | cat |
dc.publisher | Servei Català de la Salut |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.source | Scientia |
dc.subject | Artrosi - Tractament |
dc.subject | Medicaments - Ús |
dc.subject.mesh | Joint Diseases |
dc.subject.mesh | /drug therapy |
dc.subject.mesh | Glucosamine |
dc.subject.mesh | Chondroitin Sulfates |
dc.title | Document informatiu dels fàrmacs d'acció lenta sobre els símptomes de l'artrosi (SYSADOA) |
dc.type | info:eu-repo/semantics/report |
dc.subject.decs | artropatías |
dc.subject.decs | /farmacoterapia |
dc.subject.decs | glucosamina |
dc.subject.decs | sulfatos de condroitina |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |